文献速递血栓与止血

COVID-19重症患者凝血、内皮功能与纤溶生物标志物的前瞻性纵向研究

Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID-19: A single-center prospective longitudinal study.
PubMed 文献 · J Thromb Haemost · 2021-05-01

该单中心前瞻性纵向研究纳入14例COVID-19阳性ICU患者,并与14例COVID-19阴性ICU患者及健康对照匹配,每日采血检测10种生物标志物。结果发现D-二聚体升高是区分COVID-19状态的最强指标但与生存无关;血栓溶解时间、sTM、PAI-1和纤溶酶原与死亡相关,纵向聚类可区分低死亡率(30%)和高死亡率(100%)两组。

要点

  • D-二聚体升高可区分COVID-19状态,但与生存无关。
  • 血栓溶解时间、sTM、PAI-1和纤溶酶原与死亡相关。
  • 纵向聚类识别出低死亡率(30%)和高死亡率(100%)两组。

核心结论

  • 血栓溶解时间、sTM、PAI-1和纤溶酶原的纵向轨迹可能对COVID-19死亡率具有预测能力。

研究设计与样本

  • 单中心前瞻性纵向研究,纳入14例COVID-19阳性ICU成人患者,按年龄和性别匹配14例COVID-19阴性ICU患者及健康对照,每日采血并收集临床数据。

主要发现

  • D-二聚体升高是区分COVID-19状态的最强贡献指标,但D-二聚体与生存无关。
  • 变量选择识别出血栓溶解时间、可溶性血栓调节蛋白(sTM)、纤溶酶原激活物抑制剂-1(PAI-1)和纤溶酶原抗原水平为与死亡相关的生物标志物。
  • 基于上述标志物的纵向多变量k-means聚类识别出两个COVID-19阳性患者聚类:低死亡率组(30%)和高死亡率组(100%)。
  • 高死亡率聚类组的生物标志物轨迹特征为血栓溶解时间更高(纤溶受抑)、sTM和PAI-1水平更高、纤溶酶原水平更低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Immunothrombosis and coagulopathy in the lung microvasculature may lead to lung injury and disease progression in coronavirus disease 2019 (COVID-19). We aim to identify biomarkers of coagulation, endothelial function, and fibrinolysis that are associated with disease severity and may have prognostic potential. METHODS: We performed a single-center prospective study of 14 adult COVID-19(+) intensive care unit patients who were age- and sex-matched to 14 COVID-19(-) intensive care unit patients, and healthy controls. Daily blood draws, clinical data, and patient characteristics were collected. Baseline values for 10 biomarkers of interest were compared between the three groups, and visualized using Fisher's linear discriminant function. Linear repeated-measures mixed models were used to screen biomarkers for associations with mortality. Selected biomarkers were further explored and entered into an unsupervised longitudinal clustering machine learning algorithm to identify trends and targets that may be used for future predictive modelling efforts. RESULTS: Elevated D-dimer was the strongest contributor in distinguishing COVID-19 status; however, D-dimer was not associated with survival. Variable selection identified clot lysis time, and antigen levels of soluble thrombomodulin (sTM), plasminogen activator inhibitor-1 (PAI-1), and plasminogen as biomarkers associated with death. Longitudinal multivariate k-means clustering on these biomarkers alone identified two clusters of COVID-19(+) patients: low (30%) and high (100%) mortality groups. Biomarker trajectories that characterized the high mortality cluster were higher clot lysis times (inhibited fibrinolysis), higher sTM and PAI-1 levels, and lower plasminogen levels. CONCLUSIONS: Longitudinal trajectories of clot lysis time, sTM, PAI-1, and plasminogen may have predictive ability for mortality in COVID-19.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Juneja GK, Castelo M, Yeh CH, et al. Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID-19: A single-center prospective longitudinal study. J Thromb Haemost. 2021. PMID: 33826233. doi:10.1111/jth.15327

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。